Complement in ischemia reperfusion injury

American Journal of Pathology

Volumn 162, Issue 2, 2003, Pages 363-367

  Riedemann, Niels C ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE CARBOXYPEPTIDASE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; LACTATE DEHYDROGENASE; LECTIN; LIPOPOLYSACCHARIDE; MEMBRANE COFACTOR PROTEIN; MYELOPEROXIDASE; OXYGEN RADICAL; PROPERDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; APOPTOSIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART INFARCTION; INTESTINE ISCHEMIA; ISCHEMIA; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATORY BURST; STROKE; TISSUE INJURY;

EID: 0037331561     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63830-8     Document Type: Note

References (56)

1. Stahl G, Xu Y, Hau L, Miller M, Buras JA, Fung M, Zhao H: Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003, 162:449-455
2. Milhoan KA, Lane TA, Bloor CM: Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF Am J Physiol 1992, 263:H956-H962
3. Lucchesi BR: Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion. Cardiovasc Clin 1987, 18:35-48
4. Goldman G, Welbourn R, Klausner JM, Valeri CR, Shepro D, Hechtman HB: Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Circ Res 1991, 68:1013-1019
5. Jerome SN, Dore M, Paulson JC, Smith CW, Korthuis RJ: P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. Am J Physiol 1994, 266:H1316-H1321
6. Paterson IS, Klausner JM, Goldman G, Kobzik L, Welbourn R, Valeri CR, Shepro D, Hechtman HB: Thromboxane mediates the ischemia-induced neutrophil oxidative burst. Surgery 1989, 106:224-229
7. Lucchesi BR: Myocardial ischemia, reperfusion, and free radical injury. Am J Cardiol 1990, 65:141-231
8. Hill JH, Ward PA: The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 1971, 133:885-900
9. Mollnes TE, Song WC, Lambris JD: Complement in inflammatory tissue damage and disease. Trends Immunol 2002, 23:61-64
10. Shin HS, Snyderman R, Friedman E, Mellors A, Mayer MM: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 1968, 162:361-363
11. Goldstein IM, Weissmann G: Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes J Immunol 1974, 113:1583-1588
12. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS: Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 1978, 61:1161-1167
13. Schumacher WA, Fantone JC, Kunkel SE, Webb RC, Lucchesi BR: The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions 1991, 34:345-349
14. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH: Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000, 105:1363-1371
15. Ito W, Schafer HJ, Bhakdi S, Klask R, Hansen S, Schaarschmidt S, Schofer J, Hugo F, Hamdoch T, Mathey D: Influence of the terminal complement-complex on reperfusion injury, no-reflow, and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Cardiovasc Res 1996, 32:294-305
16. Stahl GL, Reenstra WR, Frendl G: Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries: role of the terminal membrane attack complex. Circ Res 1995, 76:575-583
17. Maroko PR, Carpenter CB, Chiariello M, Fishbein MC, Radvany P, Knostman JD, Hale SL: Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 1978, 61:661-670
18. Stein SH, Osgood RW, Barnes JL, Reineck HJ, Pinckard RN, McManus LM: The role of complement in the pathogenesis of postischemic acute renal failure. Miner Electrolyte Metab 1985, 11:256-261
19. Weisman HF, Bartow T, Leppo MK, Marsh Jr HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249:146-151
20. Zacharowski K, Otto M, Hafner G, Marsh Jr HC, Thiemermann C: Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol 1999, 128:945-952
21. Schmid RA, Zollinger A, Singer T, Hillinger S, Leon-Wyss JR, Schob OM, Hogasen K, Zund G, Patterson GA, Weder W: Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine. J Thorac Cardiovasc Surg 1998, 116:90-97
22. Stammberger U, Hamacher J, Hillinger S, Schmid RA: sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation. J Thorac Cardiovasc Surg 2000, 120:1078-1084
23. Lehmann TG, Koeppel TA, Kirschfink M, Gebhard MM, Herfarth C, Otto G, Post S: Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. Transplantation 1998, 66:717-722
24. Lehmann TG, Koeppel TA, Munch S, Heger M, Kirschfink M, Klar E, Post S: Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia. Microvasc Res 2001, 62:284-292
25. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore Jr FD: Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992, 149:1723-1728
26. Huang J, Kim LJ, Mealey R, Marsh Jr HC, Zhang Y, Tenner AJ, Connolly Jr ES, Pinsky DJ: Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999, 285:595-599
27. Kyriakides C, Wang Y, Austen Jr WG, Favuzza J, Kobzik L, Moore Jr FD, Hechtman HB: Moderation of skeletal muscle reperfusion injury by a sLe(x)-glycosylated complement inhibitory protein. Am J Physiol 2001, 281:C224-C230
28. Horstick G, Heimann A, Gotze O, Hafner G, Berg O, Boehmer P, Becker P, Darius H, Rupprecht HJ, Loos M, Bhakdi S, Meyer J, Kempski O: Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 1997, 95:701-708
29. Horstick G, Berg O, Heimann A, Gotze O, Loos M, Hafner G, Bierbach B, Petersen S, Bhakdi S, Darius H, Horstick M, Meyer J, Kempski O: Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation 2001, 104:3125-3131
30. Buerke M, Murohara T, Lefer AM: Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion Circulation 1995, 91:393-402
31. Salvatierra A, Velasco F, Rodriguez M, Alvarez A, Lopez-Pedrera R, Ramirez R, Carracedo J, Lopez-Rubio F, Lopez-Pujol A, Guerrero R: C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog. Am J Respir Crit Care Med 1997, 155:1147-1154
32. Scherer M, Demertzis S, Langer F, Moritz A, Schafers HJ: C1-esterase inhibitor reduces reperfusion injury after lung transplantation. Ann Thorac Surg 2002, 73:233-238; discussion 238-239
33. Buerke M, Prufer D, Dahm M, Oelert H, Meyer J, Darius H: Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 1998, 286:429-438
34. Buerke M, Schwertz H, Seitz W, Meyer J, Darius H: Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J Immunol 2001, 167:5375-5380
35. Kroshus TJ, Salerno CT, Yeh CG, Higgins PJ, Bolman III RM, Dalmasso AP: A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation. Transplantation 2000, 69:2282-2289
36. Jordan JE, Montalto MC, Stahl GL: Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 2001, 104:1413-1418
37. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, Buras JA, Meri S, Stahl GL: Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000, 156:1549-1556
38. Arumugam TV, Shiels IA, Woodruff TM, Reid RC, Fairlie DP, Taylor SM: Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J Surg Res 2002, 103:260-267
39. Wada K, Montalto MC, Stahl GL: Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology 2001, 120:126-133
40. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL: Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998, 97:2259-2267
41. Tofukuji M, Stahl GL, Agah A, Metals C, Simons M, Sellke FW: Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. J Thorac Cardiovasc Surg 1998, 116:1060-1068
42. Amsterdam EA, Stahl GL, Pan HL, Rendig SV, Fletcher MP, Longhurst JC: Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol 1995, 268:H448-H457
43. Weiser MR, Williams JP, Moore FD Jr., Kobzik L, Ma M, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996, 183:2343-2348
44. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore Jr FD, Carroll MC, Hechtman HB: Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999, 86:938-942
45. Jiang H, Wagner E, Zhang H, Frank MM: Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med 2001, 194:1609-1616
46. Undar A, Eichstaedt HC, Clubb FJ Jr., Fung M, Lu M, Bigley JE, Vaughn WK, Fraser Jr CD: Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass. Ann Thorac Surg 2002, 74:355-362; discussion 362
47. Xu Y, Ma M, Ippolito GC, Schroeder Jr HW, Carroll MC, Volanakis JE: Complement activation in factor D-deficient mice. Proc Natl Acad Sci USA 2001, 98:14577-14582
48. Taylor PR, Nash JT, Theodoridis E, Bygrave AE, Walport MJ, Botto M: A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J Biol Chem 1998, 273:699-1704
49. Zhao H, Montalto MC, Pfeiffer KJ, Hao L, Stahl GL: Murine model of gastrointestinal ischemia associated with complement-dependent injury. J Appl Physiol 2002, 93:338-345
50. Rehrig S, Fleming SD, Anderson J, Guthridge JM, Rakstang J, McQueen CE, Holers VM, Tsokos GC, Shea-Donohue T: Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J Immunol 2001, 167:5921-5927
51. Austen Jr WG, Kyriakides C, Favuzza J, Wang Y, Kobzik L, Moore Jr FD, Hechtman HB: Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 1999, 126:343-348
52. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T: Anti-inflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 1999, 90:266-275
53. Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML: Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: a possible initiator of an extra myocardial mechanism of ischemic injury Circ Res 1985, 57:119-130
54. Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O'Rourke RA: Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 1975, 56:740-750
55. Bauernschmitt R, Bohrer H, Hagl S: Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA. Intensive Care Med 1998, 24:635-638
56. Fitch JC, Rollins S, Matis L, Alford B, Aranki S, Collard CD, Dewar M, Elefteriades J, Hines R, Kopf G, Kraker P, Li L, O'Hara R, Rinder C, Rinder H, Shaw R, Smith B, Stahl G, Shernan SK: Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999, 100:2499-2506